Country deep-dive
Single-country regulatory or market reports. How peptides actually move through Danish customs; what the BfArM said about a specific schedule shift; the German press response to a Mounjaro shortage.
BPC-157 UK import rules: the MHRA position
BPC-157 has no UK marketing authorisation and no approved import route for personal use. Here is what the MHRA framework and border rules mean.
Tirzepatide in Sweden: import rules
In Sweden, tirzepatide (Mounjaro) is prescription-only and EU-authorised. Importing from outside the EEA requires dispensation and risks customs seizure.
Tirzepatide in Sweden: licence and cost
Mounjaro (tirzepatide) is licensed and prescribable in Sweden but sits outside the high-cost protection scheme. Here is what changed and what patients pay.
Tesamorelin in Sweden: regulatory status
Tesamorelin has no EU marketing authorisation. The EMA application was withdrawn in 2012. What the Swedish MPA position means for access.
Tesamorelin in Sweden: import rules
Tesamorelin has no EU authorisation. Swedish Customs bars personal imports from outside the EEA. Here is what that means in practice.
TB-500 in Sweden: regulatory status 2026
TB-500 has no authorisation from Läkemedelsverket or the EMA. Here is how Swedish law classifies it and what changed.
Retatrutide in Sweden: no approval yet
Retatrutide holds no EMA or Läkemedelsverket authorisation as of July 2026. Here is where the TRIUMPH trials stand and what that means for Swedish patients.
Semax in Sweden: regulatory status
Semax has no marketing authorisation in Sweden or the EU. Here is the Läkemedelslagen framework, what changed in 2025-2026, and who to ask.
TB-500 cost in the Netherlands
TB-500 has no EU marketing authorisation and no Dutch insurance coverage. No verified pharmacy price exists in the Netherlands.
TB-500 in the Netherlands: legal status
TB-500 has no marketing authorisation in the Netherlands. This page explains how the Geneesmiddelenwet, the CBG-MEB register, and the WADA sport ban apply.
Tesamorelin Netherlands: import rules
Tesamorelin has no EU marketing authorisation. The Netherlands has no registered product. What Dutch law, CBG-MEB rules, and customs mean for personal import.
Tesamorelin Netherlands: regulatory status
Tesamorelin has no EU marketing authorisation. The EMA application was withdrawn in 2012. Here is what Dutch patients and clinicians need to know.